You are here
EUTOS - The European Treatment Outcome Study
EUTOS.
Through the European Treatment and Outcome Study for CML programme, Novartis and the European LeukemiaNet are pleased to offer plasma imatinib monitoring free of charge (for sample transportation and dosing).
The pharmacological monitoring project has been designed to help physicians optimise treatment with imatinib.